Infant with status epilepticus secondary to systemic lidocaine toxicity from topical application.

Autor:	Walters E; Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Wurster Ovalle V; Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Yin S; Drug and Poison Information Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Dribin T; Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA timothy.dribin@cchmc.org.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Jazyk:	angličtina
Zdroj:	BMJ case reports [BMJ Case Rep] 2020 Jan 12; Vol. 13 (1). Date of Electronic Publication: 2020 Jan 12.
DOI:	10.1136/bcr-2019-233119
Abstrakt:	A previously healthy 11-month-old infant presented to the emergency department in status epilepticus. There was no clear trigger of her seizure activity which resolved with benzodiazepines and fosphenytoin. On further review, her parents disclosed that she had been prescribed topical 4% lidocaine cream for a groin rash and was ultimately diagnosed with lidocaine toxicity in the emergency department. She was monitored in the intensive care unit without cardiovascular abnormalities or recurrence of seizure activity. Emergency medicine providers must maintain a broader differential of status epileptics and be able to recognise and manage potential complications from systemic lidocaine toxicity. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu